• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

series B

An artists depiction of different types of blood cells from bone marrow
Biotech

Marrow extracts $120M series B for blood disease drug

Marrow Therapeutics’ in vivo drug candidate targets sickle cell disease and beta thalassemia with buy-in from healthcare investment giant OrbiMed.
Michael Gibney Nov 17, 2026 7:00am
cash money

Addex spinout raises $105M series B for schizophrenia ph. 2

Nov 12, 2026 3:56am
Pipette dripping water droplet with money symbol on it into test tube

T-Therapeutics raises $133M series B with Big Pharma backers

Nov 5, 2026 4:00am
blue tennis court with tennis balls and racquets

Matchpoint nets $150M series B to take covalent med into clinic

Oct 7, 2026 8:15am
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Pfizer vet debuts Khartis with sights set on thyroid eye disease

Aug 13, 2026 9:00am
Network of blood vessels against a white background

Vaderis' $152M to fund ph. 3 trial in rare blood vessel disorder

Aug 11, 2026 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings